- Home
- DOX vs PCVX Comparison
DOX vs PCVX Comparison
Compare DOX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOX
- PCVX
- Stock Information
- Founded
- DOX 1982
- PCVX 2013
- Country
- DOX United States
- PCVX United States
- Employees
- DOX N/A
- PCVX N/A
- Industry
- DOX EDP Services
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- DOX Technology
- PCVX Health Care
- Exchange
- DOX Nasdaq
- PCVX Nasdaq
- Market Cap
- DOX 10.2B
- PCVX 4.4B
- IPO Year
- DOX 1998
- PCVX 2020
- Fundamental
- Price
- DOX $91.73
- PCVX $33.27
- Analyst Decision
- DOX Strong Buy
- PCVX Strong Buy
- Analyst Count
- DOX 3
- PCVX 10
- Target Price
- DOX $105.33
- PCVX $136.50
- AVG Volume (30 Days)
- DOX 719.0K
- PCVX 1.5M
- Earning Date
- DOX 08-06-2025
- PCVX 08-05-2025
- Dividend Yield
- DOX 2.31%
- PCVX N/A
- EPS Growth
- DOX 6.36
- PCVX N/A
- EPS
- DOX 4.74
- PCVX N/A
- Revenue
- DOX $4,752,199,000.00
- PCVX N/A
- Revenue This Year
- DOX N/A
- PCVX N/A
- Revenue Next Year
- DOX $4.26
- PCVX N/A
- P/E Ratio
- DOX $19.46
- PCVX N/A
- Revenue Growth
- DOX N/A
- PCVX N/A
- 52 Week Low
- DOX $77.17
- PCVX $27.66
- 52 Week High
- DOX $95.41
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- DOX 50.54
- PCVX 46.99
- Support Level
- DOX $90.36
- PCVX $32.00
- Resistance Level
- DOX $93.12
- PCVX $34.63
- Average True Range (ATR)
- DOX 1.69
- PCVX 1.31
- MACD
- DOX -0.19
- PCVX -0.08
- Stochastic Oscillator
- DOX 27.13
- PCVX 37.46
About DOX Amdocs Limited
Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.